Výsledky vyhledávání - "Sowmya Goranta"

Direct oral anticoagulant versus low-molecular-weight heparin for treatment of venous thromboembolism in cancer patients: An updated meta-analysis of randomized controlled trials

Autor: Soheir S. Adam, Yazan Zayed, Sowmya Goranta, Smit Deliwala, Anoosha Ponnapalli, Josiane Kerbage, Tarek Haykal, Varun Samji, Srikanth Malladi

Publikováno v: Thrombosis Research. 194:57-65

Background Cancer associated venous thromboembolism (VTE) results in significant morbidity and mortality. Low molecular weight heparin (LMWH) has been standard of care for treatment of cancer-associated VTE, however direct oral anticoagulants (DOACs)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d58fdbbd3bb3b62a3d011ec68e07af82
https://doi.org/10.1016/j.thromres.2020.06.025

Zobrazit plný text záznamu

Safety and efficacy of aspirin for primary prevention of cancer: a meta-analysis of randomized controlled trials

Autor: Josiane Kerbage, Khalil Katato, Tarek Haykal, Babikir Kheiri, Mahmoud Barbarawi, Anitha Yelangi, Varun Samji, Yazan Zayed, Harsukh Dhillon, Sowmya Goranta, Ghassan Bachuwa, Adam Chahine

Publikováno v: Journal of Cancer Research and Clinical Oncology. 145:1795-1809

In the United States, cancer is the second leading cause of mortality, and millions more battle cancer worldwide. As such, primary prevention of cancer is a major interest globally. Aspirin has been studied as a primary prevention method for multiple

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2261369f2b1d270b2edab161d3019fd
https://doi.org/10.1007/s00432-019-02932-0

Zobrazit plný text záznamu

Severe primary refractory thrombotic thrombocytopenic purpura (TTP) in the post plasma exchange (PEX) and rituximab era

Autor: Tarek Haykal, Sowmya Goranta, Smit Deliwala, Ghassan Bachuwa

Publikováno v: BMJ Case Rep

Acute acquired thrombotic thrombocytopenic purpura (TTP) requires prompt recognition and initiation of plasma exchange (PEX) therapy and immunosuppression. When PEX fails, mortality nears 100%, making finding an effective treatment crucial. Primary r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9818c24301feaa9b33e89bb0ee2362c0
https://europepmc.org/articles/PMC7295375/

Zobrazit plný text záznamu

Patient and provider factors associated with the noninitiation of tamoxifen for young women at high-risk for the development of breast cancer

Autor: Megan Yanik, Jacqueline S. Jeruss, Jeannie Kochkodan, Kathryn J Huber-Keener, Danijela Dokic, Natalie Rizk, Samantha L. Estevez, Sowmya Goranta, Pridvi Kandagatla

Publikováno v: Breast J

We sought to identify factors associated with disparities in tamoxifen utilization among young patients at high-risk for developing breast cancer. We identified 67 premenopausal, high-risk women age 35-45, without surgical prophylaxis, who did not in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35ed17d69995f301368ef92ec769d3f2
https://pubmed.ncbi.nlm.nih.gov/31538708

Zobrazit plný text záznamu

PADUA score as a predictor for pulmonary embolism: a potential strategy for reducing unnecessary imaging

Autor: Pridvi Kandagatla, Sowmya Goranta, Seyed Mani Marashi, Nathan Schmoekel, Arielle H Gupta, Heath J. Antoine

Publikováno v: Journal of thrombosis and thrombolysis. 47(4)

An objective tool that is easy to integrate with an electronic medical record may help reduce unnecessary imaging for diagnosing a pulmonary embolism (PE). In this study, we assess the PADUA score in stratifying patients based on their risk of a PE.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11f04425aaadda6aebff5b8dc39a401d
https://pubmed.ncbi.nlm.nih.gov/30612328

Zobrazit plný text záznamu

Does chemotherapy affect survival of breast cancer (BC) patients with recurrence score 26-30?

Autor: Swathi Gorle, Shima Sidahmed, UyoyoTonte Omaduvie, Ghassan Bachuwa, Areeg Bala, Trailokya Nath Pandit, Eduard Drizik, Tarek Haykal, Sowmya Goranta, Khalil Katato, Ashok Kumar Kanugula

Publikováno v: Journal of Clinical Oncology. 38:523-523

523 Background: The Oncotype-DX recurrence score (RS) allows providers to identify hormone receptor positive and HER2-negative breast cancer (BC) patients that may benefit from adjuvant chemotherapy (AC). The TAILORx Trial showed no benefit of AC amo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::66fa27aae4acca5e617b6b792b105147
https://doi.org/10.1200/jco.2020.38.15_suppl.523

Zobrazit plný text záznamu

Characteristics and Trends of Sickle Cell Disease Patients Once Presented to the Emergency Department, Reflecting on a Possible Burden: United States (2010-2015)

Autor: Sowmya Goranta, Tarek Haykal, Smit Deliwala, Ragheed Al-Dulaimi, Varun Samji, Josiane Kerbage, Ghassan Bachuwa

Publikováno v: Blood. 134:4845-4845

Background: Sickle cell disease (SCD) is an autosomal recessive, multisystem disorder, characterized by chronic hemolytic anemia, painful episodes of vaso-occlusion, progressive organ failure and a reduced life expectancy. SCD is the most common mono

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b52ce6f0a863a793a015cd8d5b01f5f1
https://doi.org/10.1182/blood-2019-126871

Zobrazit plný text záznamu

Safety and efficacy of aspirin for primary prevention of cancer: A meta-analysis of randomized controlled trials

Autor: Anitha Yelangi, Tarek Haykal, Harsukh Dhillon, Babikir Kheiri, Mahmoud Barbarawi, Varun Samji, Khalil Katato, Adam Chahine, Yazan Zayed, Ghassan Bachuwa, Sowmya Goranta

Publikováno v: Journal of Clinical Oncology. 37:1533-1533

1533 Background: In the United States, cancer is the second leading cause of mortality, and millions more battle cancer worldwide. As such, primary prevention of cancer is a major interest globally. Aspirin has been studied as a primary prevention me

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9ea3988b0389d3bdbe1d57a374eebcfd
https://doi.org/10.1200/jco.2019.37.15_suppl.1533

Zobrazit plný text záznamu

Predictors of adjuvant chemotherapy for breast cancer patients with an intermediate Oncotype-DX score: A SEER-based population study

Autor: Sowmya Goranta, Trailokya Nath Pandit, Areeg Bala, Rizwan Danish, Ragheed Al-Dulaimi, Ghassan Bachuwa, Tarek Haykal

Publikováno v: Journal of Clinical Oncology. 37:e12014-e12014

e12014 Background: Oncotype-DX Assay is a 21-gene based recurrence score (RS) that helps stratify breast cancer patients based on their risk of recurrence. It is often used to help identify patients that may benefit from adjuvant chemotherapy (AC). P

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::00e46645947dbf9bfd1a8fbc4fea71be
https://doi.org/10.1200/jco.2019.37.15_suppl.e12014

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání